These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9266798)

  • 1. 2'3'-Dideoxyinosine inhibits the humoral immune response in female B6C3F1 mice by targeting the B lymphocyte.
    Phillips KE; Munson AE
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):260-7. PubMed ID: 9266798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotoxicity of 2',3'-dideoxyinosine in female B6C3F1 mice.
    Phillips KE; McCay JA; Brown RD; Musgrove DL; Meade BJ; Butterworth LF; Wilson S; White KL; Munson AE
    Drug Chem Toxicol; 1997 Aug; 20(3):189-228. PubMed ID: 9292277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A T-cell-dependent humoral immune response is preserved during the administration of the nerve agent pre-treatment pyridostigmine bromide in a murine model.
    Griffiths GD; Telford G; Hooi DS; Cook DL; Wilkinson LJ; Green CA; Pritchard DI
    Int Immunopharmacol; 2005 Mar; 5(3):525-40. PubMed ID: 15683849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of macrophage accessory cell function in casein-treated B6C3F1 mice.
    Kaminski NE; Holsapple MP
    J Immunol; 1987 Sep; 139(6):1804-10. PubMed ID: 3624870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
    Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
    J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
    Sato S; Miller AS; Howard MC; Tedder TF
    J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen affinity controls rapid T-dependent antibody production by driving the expansion rather than the differentiation or extrafollicular migration of early plasmablasts.
    Chan TD; Gatto D; Wood K; Camidge T; Basten A; Brink R
    J Immunol; 2009 Sep; 183(5):3139-49. PubMed ID: 19666691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin potentiates the efficacy and toxicity of 2',3'- dideoxyinosine in the murine acquired immunodeficiency syndrome model.
    Harvie P; Omar RF; Dusserre N; Lansac N; Désormeaux A; Gourde P; Simard M; Tremblay M; Beauchamp D; Bergeron MG
    J Pharmacol Exp Ther; 1996 Nov; 279(2):1009-17. PubMed ID: 8930211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The B lymphocyte is the immune cell target for 2',3'-dideoxyadenosine.
    Cao W; Sikorski EE; Fuchs BA; Stern ML; Luster MI; Munson AE
    Toxicol Appl Pharmacol; 1990 Sep; 105(3):492-502. PubMed ID: 2237921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage: II. Effects of the individual agents compared to combination treatment.
    Witt KL; Tice RR; Wolfe GW; Bishop JB
    Environ Mol Mutagen; 2004; 44(4):321-8. PubMed ID: 15476197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel immunoregulatory B cell pathways revealed by lpr-+ mixed chimeras.
    Sobel ES; Kakkanaiah VN; Schiffenbauer J; Reap EA; Cohen PL; Eisenberg RA
    J Immunol; 1998 Feb; 160(3):1497-503. PubMed ID: 9570572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
    Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
    J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique characteristics of lacrimal glands as a part of mucosal immune network: high frequency of IgA-committed B-1 cells and NK1.1+ alphabeta T cells.
    Saitoh-Inagawa W; Hiroi T; Yanagita M; Iijima H; Uchio E; Ohno S; Aoki K; Kiyono H
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):138-44. PubMed ID: 10634613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody class switching differs among SJL, C57BL/6 and 129 mice.
    Kaminski DA; Stavnezer J
    Int Immunol; 2007 Apr; 19(4):545-56. PubMed ID: 17329233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters governing exhaustion of rare T cell-independent neutralizing IgM-producing B cells after LCMV infection.
    Zellweger RM; Hangartner L; Weber J; Zinkernagel RM; Hengartner H
    Eur J Immunol; 2006 Dec; 36(12):3175-85. PubMed ID: 17125146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.